false Q3 2026 --12-31 0001807689 0001807689 2026-01-01 2026-09-30 0001807689 2026-11-12 0001807689 2026-09-30 0001807689 2025-12-31 0001807689 2026-07-01 2026-09-30 0001807689 2025-07-01 2025-09-30 0001807689 2025-01-01 2025-09-30 0001807689 us-gaap:PreferredStockMember 2025-12-31 0001807689 us-gaap:CommonStockMember 2025-12-31 0001807689 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001807689 us-gaap:RetainedEarningsMember 2025-12-31 0001807689 us-gaap:PreferredStockMember 2026-06-30 0001807689 us-gaap:CommonStockMember 2026-06-30 0001807689 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001807689 us-gaap:RetainedEarningsMember 2026-06-30 0001807689 2026-06-30 0001807689 us-gaap:PreferredStockMember 2024-12-31 0001807689 us-gaap:CommonStockMember 2024-12-31 0001807689 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001807689 us-gaap:RetainedEarningsMember 2024-12-31 0001807689 2024-12-31 0001807689 us-gaap:PreferredStockMember 2025-06-30 0001807689 us-gaap:CommonStockMember 2025-06-30 0001807689 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001807689 us-gaap:RetainedEarningsMember 2025-06-30 0001807689 2025-06-30 0001807689 us-gaap:PreferredStockMember 2026-01-01 2026-09-30 0001807689 us-gaap:CommonStockMember 2026-01-01 2026-09-30 0001807689 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-09-30 0001807689 us-gaap:RetainedEarningsMember 2026-01-01 2026-09-30 0001807689 us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001807689 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001807689 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001807689 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001807689 us-gaap:PreferredStockMember 2025-01-01 2025-09-30 0001807689 us-gaap:CommonStockMember 2025-01-01 2025-09-30 0001807689 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-09-30 0001807689 us-gaap:RetainedEarningsMember 2025-01-01 2025-09-30 0001807689 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001807689 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001807689 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001807689 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001807689 us-gaap:PreferredStockMember 2026-09-30 0001807689 us-gaap:CommonStockMember 2026-09-30 0001807689 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001807689 us-gaap:RetainedEarningsMember 2026-09-30 0001807689 us-gaap:PreferredStockMember 2025-09-30 0001807689 us-gaap:CommonStockMember 2025-09-30 0001807689 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001807689 us-gaap:RetainedEarningsMember 2025-09-30 0001807689 2025-09-30 0001807689 2020-04-13 0001807689 eaiq:GDSLuminaIncMember 2025-09-23 0001807689 eaiq:EyeonixMedMember 2026-01-01 2026-09-30 0001807689 eaiq:CKLLCMember 2026-09-30 0001807689 eaiq:OfficerAndDirectorMember 2026-09-30 0001807689 eaiq:OfficerAndDirectorMember 2025-12-31 0001807689 eaiq:OfficerAndDirectorMember 2026-01-01 2026-09-30 0001807689 eaiq:OfficerAndDirectorMember 2025-01-01 2025-09-30 0001807689 eaiq:EconomicInjuryDisasterLoansMember 2021-12-31 0001807689 eaiq:EconomicInjuryDisasterLoansMember 2020-01-01 2021-12-31 0001807689 2025-01-01 2025-12-31 0001807689 eaiq:BeverageSalesMember 2026-01-01 2026-09-30 0001807689 eaiq:BeverageSalesMember 2025-01-01 2025-09-30 0001807689 eaiq:BeverageProductCostsMember 2026-01-01 2026-09-30 0001807689 eaiq:BeverageProductCostsMember 2025-01-01 2025-09-30 0001807689 us-gaap:SubsequentEventMember us-gaap:RestrictedStockMember 2026-11-01 2026-11-03 0001807689 us-gaap:SubsequentEventMember us-gaap:RestrictedStockMember 2026-11-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☑ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 for the quarterly period ended September 30, 2026

 

☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 for the transition period from ____________ to ____________.

 

Commission file number:  000-54457

 

EYEONIX AIQ, INC.

(Exact name of registrant as specified in its charter)

 

Wyoming   83-4100110
(State of incorporation)   (IRS Employer Identification No.)
 
30 N Gould Street #60224
Sheridan, WY 82801
(Address of principal executive offices) (Zip Code)
 
(727) 692-3348
(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Name of each exchange on which registered Ticker symbol
N/A N/A N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes þ   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ   No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer”, "accelerated filer,” "smaller reporting company” and "emerging growth company” in rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☑ Smaller reporting company ☑
    Emerging growth company ☑

 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐   No ☑

 

As of November 12, 2026, there were 26,194,754 issued and outstanding shares of common stock.

 
 
 

 

TABLE OF CONTENTS

 

 

PART I. FINANCIAL INFORMATION  
   
Item 1. Financial Statements 3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
Item 3. Quantitative and Qualitative Disclosures about Market Risk 16
Item 4. Controls and Procedures 16
     
PART II. OTHER INFORMATION 17
   
Item 1. Legal Proceedings 17
Item 1A. Risk Factors 17
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 17
Item 3. Defaults Upon Senior Securities 17
Item 4. Mine Safety Disclosures 17
Item 5. Other Information 17
Item 6. Exhibits 18
  Signatures 19

 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

EYEONIX AIQ, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

           
   September 30,
2026
   December 31,
2025
 
ASSETS          
CURRENT ASSETS          
Cash  $68,458   $202 
Accounts receivable   —    9,300 
Prepaid expenses   2,500    625 
Total current assets   70,958    10,127 
TOTAL ASSETS  $70,958   $10,127 
           
 LIABILITIES AND STOCKHOLDERS' EQUITY          
Current liabilities:          
Accounts payable and accrued expenses  $6,480   $30,981 
Advances payable, related party   19,842    19,481 
Notes payable, related party   10,000    — 
Total current liabilities   36,322    50,462 
           
Other non-current liabilities:          
Notes payable, related party   33,000    — 
SBA EID Loan 2020   114,484    114,484 
Total non-current liabilities   147,484    114,484 
 TOTAL LIABILITIES   183,806    164,946 
           
STOCKHOLDERS' DEFICIT          
Preferred stock; $0.001 par value, 20,000,000 and 20,000,000 shares authorized and 10,000,000 and 10,000,000 shares issued and outstanding   10,000    10,000 
Common stock; $0.001 par value, 750,000,000 and 750,000,000 shares authorized and 26,194,754 and 26,124,754 shares issued and outstanding   26,195    26,125 
Additional paid-in capital   1,926,184    1,856,254 
Accumulated deficit   (2,075,227)   (2,047,198)
Total stockholders' deficit   (112,848)   (154,819)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT  $70,958   $10,127 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

3 

 

EYEONIX AIQ, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

                     
   For the Three Months Ended
September 30,
   For the Nine months Ended
September 30,
 
   2026   2025   2026   2025 
REVENUES                    
Sales – Digital marketing  $27,900   $26,100   $83,700   $44,600 
                     
OPERATING EXPENSES                    
Operating expenses   17,875    7,444    53,582    11,844 
General and administrative   9,591    5,655    14,209    9,942 
Professional fees   16,030    12,597    40,728    27,434 
Total operating expenses   43,496    25,696    108,519    49,220 
Operating Income (Loss)   (15,596)   404    (24,819)   (4,620)
                     
OTHER EXPENSES                    
Gain on disposal of subsidiary   —    1,853    —    (6,146)
Interest expense   (1,082)   (1,168)   (3,210)   (3,295)
Total other expenses   (1,082)   685    (3,210)   (9,441)
Net income (loss) from continuing operations  $(16,678)  $1,089   $(28,029)  $(14,061)
                     
Net income (loss) from discontinued operations   —    —    —    (58,839)
Net income (loss)  $(16,678)  $1,089   $(28,029)  $(72,900)
                     
Basic and diluted net income (loss) per common share                    
Continuing operations  $(0.00)  $0.00   $(0.00)  $(0.00)
Discontinued operations  $—   $—   $—   $(0.00)
Basic and diluted net income (loss) per common share  $(0.00)  $0.00   $(0.00)  $(0.00)
Basic and diluted weighted average common shares outstanding   26,128,558    26,124,754    26,126,036    26,118,864 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

4 

 

EYEONIX AIQ, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

(UNAUDITED)

 

                                    
   Preferred Stock   Common Stock   Additional
Paid-in
Capital
   Accumulated
Deficit
   Total Stockholders' Deficit 
   Shares   Amount   Shares   Amount             
Balance, December 31, 2025   10,000,000   $10,000    26,124,754   $26,125   $1,856,254   $(2,047,198)  $(154,819)
                                    
Common stock issued for cash   —    —    70,000    70    69,930    —    70,000 
                                    
Net loss for the nine months ended September 30, 2026   —    —    —    —    —    (28,029)   (28,029)
Balance, September 30, 2026   10,000,000   $10,000    26,194,754   $26,195   $1,926,184   $(2,075,227)  $(112,848)
                                    

 

   Preferred Stock   Common Stock   Additional Paid-in
Capital
   Accumulated
Deficit
   Total Stockholders' Deficit 
   Shares   Amount   Shares   Amount             
Balance, June 30, 2026   10,000,000   $10,000    26,124,754   $26,125   $1,856,254   $(2,058,549)  $(166,170)
                                    
Common stock issued for cash   —    —    70,000    70    69,930    —    70,000 
                                    
Net loss for the three months ended September 30, 2026   —    —    —    —    —    (16,678)   (16,678)
Balance, September 30, 2026   10,000,000   $10,000    26,194,754   $26,195   $1,926,184   $(2,075,227)  $(112,848)

 

   Preferred Stock   Common Stock   Additional Paid-in
Capital
   Accumulated
Deficit
   Total Stockholders' Deficit 
   Shares   Amount   Shares   Amount             
December 31, 2024  10,000,000   $10,000   26,112,754   $26,113   $1,850,266   $(2,047,990)   $(161,611) 
                                    
Common stock issued for cash   —    —    12,000    12    5,988    —    6,000 
                                    
Net loss for nine months ended September 30, 2025   —    —    —    —    —    (72,900)   (72,900)
Balance, September 30, 2025   10,000,000   $10,000    26,124,754   $26,125   $1,856,254   $(2,120,890)  $(228,511)
                                    

 

   Preferred Stock   Common Stock   Additional Paid-in
Capital
   Accumulated
Deficit
   Total Stockholders' Deficit 
   Shares   Amount   Shares   Amount             
Balance, June 30, 2025   10,000,000   $10,000    26,124,754   $26,125   $1,856,254   $(2,121,979)  $(229,600)
                                    
Net income for the three months ended September 30, 2025   —    —    —    —    —    1,089    1,089 
Balance, September 30, 2025   10,000,000   $10,000    26,124,754   $26,125   $1,856,254   $(2,120,890)  $(228,511)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

5 

 

EYEONIX AIQ, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

           
   For the Nine months Ended
September 30,
 
   2026   2025 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(28,029)  $(72,900)
Adjustments to reconcile net loss to cash used by operating activities:          
Loss on disposal of subsidiary   —    7,999 
Changes in operating assets and liabilities:          
Accounts receivable   9,300    (9,300)
Prepaid assets   (1,875)   (2,005)
Leased assets   —    34,427 
Accounts payable and accrued expenses   (24,501)   8,815 
Advances payable, related party   361    — 
Lease liabilities   —    (22,500)
Net cash used in operating activities   (44,744)   (55,464)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from the issuance of notes payable, related party   43,000    56,565 
Common stock issued for cash   70,000    6,000 
Payments on notes payable, related party   —    (83)
Net cash provided by (used in) financing activities   113,000    62,482 
           
Net change in cash  $68,256   $7,018 
Cash, beginning of period  $202   $247 
           
Cash, end of period  $68,458   $7,265 
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
           
Cash paid for interest  $5,193   $3,635 
Cash paid for taxes  $—   $— 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

6 

 

EYEONIX AIQ, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2026

 

NOTE 1 - ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES

 

The financial statements presented are those of Eyeonix AIQ, Inc. (formerly “Fast Casual Concepts, Inc.”) (“Eyeonix”, or the “Company”) and its wholly owned subsidiaries, Eyeonix Med AIQ, Inc. (“Eyeonix Med”) and GDS Lumina, Inc. (“GDS”). Eyeonix was originally incorporated on March 23, 2019, under the laws of the State of Pennsylvania (PA). On April 13, 2020, the Company re-domiciled in the state of Wyoming, increasing its authorized number common shares available to be issued to 750,000,000.

 

Eyeonix was incorporated to develop, build, operate and franchise casual eating establishments. All restaurant development, building and operations were discontinued on October 1, 2022. The remaining franchising operations were discontinued during 2024 with the shuttering of the last franchised eating establishment.

 

GDS was incorporated on September 23, 2025 under the laws of the state of Wyoming to pursue digital marketing. GDS has 100,000 shares of common stock par value $0.001 per share available to be issued. All 100,000 shares of common stock are issued to Eyeonix as its parent.

 

Eyeonix Med was incorporated on July 13, 2026 under the laws of the state of Wyoming to develop, produce, market and sell the Eyeonix Command Medical Product, an intelligent medical decision tool that uses current guidelines to assist in the decision-making process of patient treatment. Eyeonix Med has 750,000,000 shares of common stock par value $0.001 per share and 100,000,000 shares of preferred stock par value $0.001 per share available to be issued. Eyeonix Med has designated Preferred Series A shares to have a 10 to 1 voting power to each share of common stock. There are 100,000 shares of common stock issued to Eyeonix as its parent.

 

On September 30, 2025, Eyeonix terminated its previous November 2024 acquisition of CK Distribution, LLC (“CK”). CK was incorporated on July 10, 2023 under the laws of the state of Florida to pursue production, market and sale of specialty drink mixes. CK was acquired by Eyeonix during November 2024 as the result of a private party agreement between the respective companies’ majority ownership, whereby, 100% ownership of the CK LLC was transferred to Eyeonix in exchange for a significant shareholder in Eyeonix transferring his personal shares to the former owner of CK. During September 2025, the parties agreed to terminate the agreement with all personal shares being returned and all liabilities of CK assumed by its new owner. As such, all balances and activity related to CK business have been shown as discontinued operations as of and for the nine months ended September 30, 2026 (see Note 5).

 

Basis of Presentation

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and the rules of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim consolidated financial statements include normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim consolidated financial statements be read in conjunction with Eyeonix's most recent audited financial statements as of December 31, 2025. Operating results for the nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the year ending December 31, 2026.

 

Revenue Recognition Policy

 

Eyeonix recognizes revenue in accordance with the provisions of Financial Accounting Standards Board (“FASB”) Accounting Series Codification (“ASC”) 606, Revenue From Contracts With Customers (“ASC 606”), which provides guidance on the recognition, presentation, and disclosure of revenue in financial statements. ASC 606 outlines the basic criteria that must be met to recognize revenue and provides guidance for disclosure related to revenue recognition policies. In general, the Company recognizes revenue based on the allocation of the transaction price to each performance obligation as each performance obligation in a contract is satisfied.

 

Eyeonix recognized revenue from the sale of digital marketing services totaling $83,700 and $44,600 for the nine months ended September 30, 2026 and 2025, respectively.

 

7 

 

EYEONIX AIQ, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2026

 

New Accounting Pronouncements

 

Eyeonix has implemented all new accounting pronouncements that are in effect and that may impact its financial statements. The Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

Basic and Diluted Loss Per Share

 

Eyeonix presents both basic and diluted earnings per share (EPS) on the face of the consolidated statements of operations for both continuing and discontinued operations. Basic EPS is computed by dividing net income (loss) from continuing and discontinued operations available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including convertible debt, stock options, and warrants, using the treasury stock method, and convertible debt instrument, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. There are no outstanding dilutive instruments as of September 30, 2026 or December 31, 2025.

 

The calculations of basic and diluted net loss per share are as follows:

 

          
   For the Nine months Ended
September 30,
 
   2026   2025 
Basic and Fully Diluted Net Loss Per Common Share:          
Numerator:          
Net loss from continuing operations  $(28,029)  $(14,061)
Net loss from discontinued operations  $—   $(58,839)
Net loss  $(28,029)  $(72,900)
Denominator:          
Basic and fully diluted weighted-average common shares outstanding   26,126,036    26,118,864 
Net loss per share from continuing operations  $(0.00)  $(0.00)
Net loss per share from discontinued operations  $—   $(0.00)
Basic and fully diluted net loss per share  $(0.00)  $(0.00)

 

NOTE 2 - RELATED PARTY TRANSACTIONS

 

Advances Payable

 

The Company owes an officer and director of the Company $19,842 and $19,481 as of September 30, 2026 and December 31, 2025, respectively, for cash advances during 2025 and 2024. The advances are due on demand, unsecured and do not bear interest.

Notes Payable

During the nine months ended September 30, 2026, an officer and director of Eyeonix loaned the Company $43,000. The loans are due December 31, 2028, with $10,000 repayable on demand, they are unsecured and do not bear interest. The balance of the related party notes payable was $43,000 and $0 at September 30, 2026 and December 31, 2025, respectively.

NOTE 3 - CARES ACT FUNDING

 

As part of the Coronavirus Aid, Relief and Economic Security Act, during 2020 through 2021, Eyeonix borrowed a total of $114,400 in Economic Injury Disaster Loans (EIDL). The EIDL are due in 30 years from the dates of issuance and the terms call for interest at 3.75% and installment payments of principal and interest of $577 per month beginning twenty-four months from the date of the original note in 2020. During 2025, $84 in fees were added to the principal balance of the loan. The balance of the EIDL was $114,484 and $114,484 at September 30, 2026 and December 31, 2025, respectively.

 

8 

 

EYEONIX AIQ, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2026

 

NOTE 4 - GOING CONCERN

 

Eyeonix's financial statements are prepared using Generally Accepted Accounting Principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. However, Eyeonix has accumulated losses since its inception and has negative cash flows from operations, which raise substantial doubt about its ability to continue as a going concern. Management's plans with respect to alleviating the adverse financial conditions that caused management to express substantial doubt about Eyeonix's ability to continue as a going concern are as follows:

 

To date, Eyeonix has raised over $1,000,000 and is seeking to raise up to $5,000,000 total through private placements of its common stock. Funds received from the issuance of debt and equity will be used to increase its digital marketing and technology services to ultimately achieve profitability. The continuation of Eyeonix as a going concern is dependent upon its ability to generate profitable operations that produce positive cash flows. If Eyeonix is not successful, it may be forced to raise additional debt or equity financing.

 

There can be no assurance that Eyeonix will be able to achieve its business plans, raise any more required capital or secure the financing necessary to achieve its current operating plan.  The ability of Eyeonix to continue as a going concern is dependent upon its ability to successfully accomplish the plan described in the preceding paragraph and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

NOTE 5 - DISCONTINUED OPERATIONS

 

During September 2025, the Company terminated its acquisition of CK from November 2024. The parties agreed to return the privately held common stock shares of Eyeonix and the owner of CK assumed all liabilities and obligations of CK as of September 30, 2026. The historical statement of operations of the specialty beverage business of CK for the year ended December 31, 2025 has been presented as discontinued operations in the consolidated financial statements.

 

The operating results of the Company’s discontinued operations for the nine months ended September 30, 2026 and 2025 are as follows:

 

          
   For the Nine months Ended
September 30,
 
   2026   2025 
REVENUES          
Beverage sales  $—   $36,854 
           
COST OF SALES          
Beverage product costs   —    35,868 
GROSS PROFIT – BEVERAGE SALES   —    986 
           
OPERATING EXPENSES          
General and administrative expenses   —    50,625 
Professional fees   —    9,200 
Total operating expenses   —    59,825 
Loss from discontinued operations  $—   $(58,839)

 

Total cash provided by operating activities of discontinued operations were $- and $11,927, respectively, for the nine months ended September 30, 2026 and 2025, respectively.

 

NOTE 6 - SUBSEQUENT EVENTS

 

On Nov. 3rd the company approved for issuance 30,000 shares of restricted stock for $30,000 cash, or $1 per share.

9 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE RESULTS

This Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they do not materialize or prove correct, could cause our results to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including, but not limited to, statements concerning: our plans, strategies and objectives for future operations; new products or developments; future economic conditions, performance or outlook; the outcome of contingencies; expected cash flows or capital expenditures; our beliefs or expectations; activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future; and assumptions underlying any of the foregoing. Forward-looking statements may be identified by their use of forward-looking terminology, such as “believes,” “expects,” “may,” “should,” “would,” “will,” “intends,” “plans,” “estimates,” “anticipates,” “projects” and similar words or expressions. You should not place undue reliance on these forward-looking statements, which reflect our management’s opinions only as of the date of the filing of this Quarterly Report on Form 10-Q and are not guarantees of future performance or actual results.

 

Overview

 

Eyeonix was incorporated to develop, build, operate and franchise casual eating establishments. All restaurant development, building, operations and franchising operations were discontinued by the end of 2024. Eyeonix acquired CK Distribution (“CK”) in November 2024 to pursue production, market and sale of specialty drink mixes. During June 2025, Eyeonix and the former owner of CK agreed to terminate the acquisition agreement. As such, all balances and activity related to the CK specialty drink mix business have been shown as discontinued operations for the nine months ended September 30, 2025.

 

On September 23, 2025, the Company incorporated GDS Lumina, Inc. (“GDS”) under the laws of the state of Wyoming to pursue digital marketing, our current operations and Eyeonix Med was incorporated on July 13, 2026 under the laws of the state of Wyoming to develop, produce, market and sell the new Eyeonix Command Medical Product.

 

Going Concern

 

At September 30, 2026, we had $70,958 in total assets, all current, $36,322 in current liabilities and a $2,075,227 accumulated deficit. Our current liquidity resources are not sufficient to fund the anticipated level of operations for at least the next 12 months from the date these consolidated financial statements were issued. As a result, there is substantial doubt regarding the Company’s ability to continue as a going concern.

 

The ability to continue Eyeonix’s operations depends on its ability to generate and grow revenue and results of operations as well as our ability to access capital markets when necessary to accomplish strategic objectives. We expect to continue to incur losses for the immediate future and will need additional equity or debt financing until we can achieve profitability and positive cash flows from operating activities. Our future capital requirements for operations will depend on many factors, including the ability to generate revenues and obtain capital.

 

There is no assurance that we will ever be profitable or that debt or equity financing will be available to us. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result should we be unable to continue as a going concern. There is no assurance we will be successful in any of these goals.

 

Results of Operations

 

For the Three Months Ended September 30, 2026 and 2025

 

Revenues

 

We recognized $27,900 and $26,100 in revenues during the three months ended September 30, 2026 and 2025, respectively, from providing digital marketing services.

 

10 

 

Operating Expenses

 

Operating expenses were $43,496 during the three months ended September 30, 2026, compared to $25,696 during the three months ended September 30, 2025. Operating expenses consisted of $17,875 and $7,444 in operating expenses such as contract labor related to the delivery of digital marketing services, $16,030 and $12,597 in professional fees and $9,591 and $5,655 in general and administrative expenses during the three months ended September 30, 2026 and 2025, respectively. Increases in operating expenses and professional fees are mainly related to the Company’s discontinuation of the specialty beverage distribution business and entry into the digital marketing business during the second quarter of 2025.

 

Other Expenses

 

Total other expenses consisted of $1,082 and $1,168 of interest expenses and $0 and $1,853 in gains from disposal of subsidiary during the three months ended September 30, 2026 and 2025, respectively.

 

Net Income (Loss)

 

As a result of the above, we recognized net loss of $16,678 and net income of $1,089 for the three months ended September 30, 2026 and 2025, respectively.

 

For the Nine months ended September 30, 2026 and 2025

 

Revenues

 

We recognized $83,700 and $44,600 in revenues during the nine months ended September 30, 2026 and 2025, respectively, from providing digital marketing services.

 

Operating Expenses

 

Operating expenses were $108,519 during the nine months ended September 30, 2026, compared to $49,220 during the nine months ended September 30, 2025. Operating expenses consisted of $53,582 and $11,844 in operating expenses such as contract labor related to the delivery of digital marketing services, $40,728 and $27,434 in professional fees and $14,209 and $9,942 in general and administrative expenses during the nine months ended September 30, 2026 and 2025, respectively. Increases in all categories are mainly related to the Company’s discontinuation of the specialty beverage distribution business and entry into the digital marketing business during the second quarter of 2025.

 

Other Expenses

 

Total other expenses consisted of $3,210 and $3,295 of interest expenses and $0 and $6,146 in losses from disposal of subsidiary during the nine months ended September 30, 2026 and 2025, respectively.

 

Net Loss from Continuing Operations

 

As a result of the above, we recognized net losses from continuing operations of $28,029 and $14,061 for the nine months ended September 30, 2026 and 2025, respectively.

 

Net Loss from Discontinued Operations

 

Net loss from discontinued operations related to the specialty beverage distribution business totaled $0 and $58,839 for the nine months ended September 30, 2026 and 2025, respectively.

 

Net Loss

 

As a result of the above, we recognized net losses of $28,029 and $72,900 for the nine months ended September 30, 2026 and 2025, respectively.

 

11 

 

Liquidity and Capital Resources of the Company

 

Total and Current Assets

 

Total assets were $70,958 and $10,127 at September 30, 2026 and December 31, 2025, respectively, all current. Current assets consisted of $68,458 in cash and $2,500 in prepaid assets. Current assets as of December 31, 2025 totaled $10,127, consisting of $202 in cash, $9,300 in accounts receivable and prepaid assets of $625.

 

Total Liabilities

 

Total liabilities were $183,806 and $164,946 at September 30, 2026 and December 31, 2025, respectively. Total liabilities consist of current liabilities of $36,322 and $50,462 and non-current liabilities of $147,484 and $114,484 at September 30, 2026 and December 31, 2025, respectively.

 

Current Liabilities

 

Current liabilities totaled $36,322 and $50,462 as of as of September 30, 2026 and December 31, 2025, respectively. Current liabilities consisted of accounts payable and accrued expenses totaling $6,480 and $30,981, respectively, notes payable, related party totaling $10,000 and $0, and advances payable to related parties totaling $19,842 and $19,481, respectively.

 

Non-Current Liabilities

 

Non-current liabilities totaled $147,484 and $114,484 as of as of September 30, 2026 and December 31, 2025, respectively. Non-current liabilities consisted of a note payable of $114,484 and $114,484, respectively, and the non-current portion of notes payable to related parties totaling $33,000 and $0, respectively.

 

Net Cash Used in Operating Activities

 

During the nine months ended September 30, 2026, our operating activities used net cash of $44,744. Uses of cash during the nine months ended September 30, 2026 are mainly due to the $28,029 net loss as well as a $1,875 increase in prepaid assets and $24,501 decrease in accounts payable and accrued expenses. Uses are partially offset by a $9,300 decrease in accounts receivable and $361 increase in advances payable to related party.

During the nine months ended September 30, 2025, our operating activities used net cash of $55,464. Uses of cash during the nine months ended September 30, 2025 are mainly due to the $72,900 in net loss, offset by $9,437 net changes in operating assets and liabilities and $7,999 in non-cash loss on disposal of subsidiary.

 

Net Cash Provided by Financing Activities

 

During the nine months ended September 30, 2026 and 2025, we received $43,000 and $56,565 from notes and advances payable from related parties and $70,000 and $6,000 in cash from the sale of common stock, respectively. During the nine months ended September 30, 2026 and 2025, we repaid $0 and $83 in notes payable, respectively.

 

At September 30, 2026 we had working capital of $44,636 and a working capital deficit of $40,335 at December 31, 2025.

 

Off-Balance Sheet Arrangements

 

We had no off-balance sheet arrangements of any kind for the nine months ended September 30, 2026 or 2025.

 

Critical Accounting Policies

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities. We continuously evaluate our critical accounting policies and estimates. We base our estimates on historical experience and on various assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ materially from these estimates under different assumptions or conditions.

 

12 

 

We believe the following critical accounting policies are important to the portrayal of our financial condition and results of operations and require our management’s subjective or complex judgment because of the sensitivity of the methods, assumptions and estimates used in the preparation of our financial statements.

 

Accounts Receivable

 

Trade accounts receivable are recorded at invoiced amounts. Eyeonix does not provide any unusual contractual trade terms, sales incentive programs or discounts. Allowances for doubtful accounts are established for estimated losses resulting from the inability of customers to make required payments. Allowances are determined based on a review of specific customer accounts where collection is doubtful, as well as an assessment of the collectability of total receivables. Receivables are written off against the allowance when it is determined that the amounts will not be recovered.

 

Revenue Recognition

 

We recognize revenue in accordance with the provisions of Financial Accounting Standards Board (“FASB”) Accounting Series Codification (“ASC”) 606, Revenue From Contracts With Customers (“ASC 606”), which provides guidance on the recognition, presentation, and disclosure of revenue in financial statements. ASC 606 outlines the basic criteria that must be met to recognize revenue and provides guidance for disclosure related to revenue recognition policies. Accordingly, we recognize revenue based on the allocation of the transaction price to each performance obligation as each performance obligation in a contract is satisfied. We generated revenue from continuing operations from the sale of digital marketing services during the nine months ended September 30, 2026.

 

Leases

 

Operating lease liabilities represented the present value of lease payments not yet paid. Operating lease assets represented rights to use an underlying asset and are based upon the operating lease liabilities adjusted for prepayments or accrued lease payments, initial direct costs, lease incentives, and impairment of operating lease assets. To determine the present value of lease payments not yet paid, incremental borrowing rates corresponding to the reasonably certain lease term were estimated. If the estimate of our incremental borrowing rate was changed, operating lease assets and liabilities could differ materially.

 

Stock Based Compensation

 

We record stock-based compensation using the fair value method. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued. All transactions with non-employees in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.

 

Income Taxes

 

We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statements and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

As a "smaller reporting company” as defined by Item 10 of Regulation S-K, we are not required to provide information required by this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act”) that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial and Accounting Officer, as appropriate to allow timely decisions regarding required disclosure.

13 

 

 

We carried out an evaluation under the supervision and with the participation of management, including our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2026, the end of the period covered by this report. Based on that evaluation, our Principal Executive Officer and Principal Financial and Accounting Officer have concluded that our disclosure controls and procedures were not effective as of September 30, 2026 due to the material weakness in our internal controls over financial reporting, including our failure to design and maintain formal accounting policies, processes, and controls to analyze, and account for complex transactions as well as a need for additional accounting personnel who have the requisite experience in SEC reporting regulation.

 

Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive officer and principal financial officer and effected by the Board, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes those policies and procedures that:

 

  ● Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;
  ● Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures of are being made only in accordance with authorizations of our management and directors; and
  ● Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

 

Because of inherent limitations, our internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal controls over financial reporting during the third quarter of 2026, which were identified in connection with management’s evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, which have materially affected, or are reasonable likely to materially affect, our internal control over financial reporting.

 

14 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None.

 

Item 1A. Risk Factors

 

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

N/A

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

EXHIBIT NO.   DESCRIPTION
     
31   CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002.
32   CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002.
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

15 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  EYEONIX AIQ, INC.
     
  By: /s/ George Athanasiadis
    Name:  George Athanasiadis
    Title:  Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ George Athanasiadis   Chief Executive Officer, President, Secretary and Director
(Principal Executive Officer and Principal Financial and Accounting Officer)
  November 12, 2026
George Athanasiadis  
     

 

16